1. Peritoneal Dialysis Is an Option for Acute Kidney Injury Management in Patients with COVID-19
- Author
-
Sergio Armeaga Aguilar, Nayeli Acosta García, Alberto Villa Torres, Leticia Herrera Arellano, Enzo Vasquez Jimenez, Magdalena Madero, Dolores Aleman Quimbiulco, and José Manuel Rodríguez-Chagolla
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Peritoneal dialysis ,Acute Lung Injury ,Review ,Disease ,Extracorporeal ,Catheterization ,Prone Position ,Ascitic Fluid ,Humans ,Medicine ,Infection control ,Renal replacement therapy ,Medical Waste Disposal ,Intensive care medicine ,Developing Countries ,Pandemics ,COVID-19 disease ,Inflammation ,Infection Control ,Kidney ,Lung ,SARS-CoV-2 ,business.industry ,Acute kidney injury ,COVID-19 ,Disease Management ,Hematology ,General Medicine ,Acute Kidney Injury ,Containment of Biohazards ,medicine.disease ,Treatment Outcome ,medicine.anatomical_structure ,Nephrology ,Cytokines ,business - Abstract
In December 2019, cases of acute respiratory illness of unknown origin were reported in Wuhan, China. The disease is caused by “severe acute respiratory syndrome coronavirus 2”. After identifying severe lung damage, injury to other organs, such as the kidney, has been identified. Peritoneal dialysis is a renal replacement therapy (RRT) and is at least as effective as other extracorporeal therapy options, with significant cost-effective advantages. However, this strategy is rarely used for the management of acute kidney injury in severe lung disease. In this review, we explore PD as an RRT strategy that may be a key instrument in countries and hospitals with limited access to all RRTs.
- Published
- 2020
- Full Text
- View/download PDF